Does Dr. RAIED ABDULLAH have financial conflicts of interest?

Dr. RAIED ABDULLAH (M.D.) has received a total of $2,367 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,367 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAIED ABDULLAH?

According to CMS Open Payments data, Dr. RAIED ABDULLAH received funding from ASTRAZENECA PHARMACEUTICALS ($526), AMGEN ($267), and VIFOR PHARMA ($240).

Does Dr. RAIED ABDULLAH receive research grants or speaking fees?

Dr. RAIED ABDULLAH has received $2,367 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAIED ABDULLAH

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: GARY, IN 46409

NPI Number: 1063417657

LIFETIME INDUSTRY VALUE

$2,367

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDULLAH is a verified Internal Medicine, Nephrology practitioner based in GARY, IN.

Between 2021 and 2024, Dr. ABDULLAH had an overall industry promotional and research financial footprint of $2,367 as recorded in the federal CMS Open Payments database.

$2,367 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDULLAH's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $526 (representing 22.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$526

22.2%

AMGEN

Rank 2

$267

11.3%

VIFOR PHARMA

Rank 3

$240

10.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.